Adoptive T-cell therapy improves treatment of canine non–Hodgkin lymphoma post chemotherapy

Viable T cells were enumerated every 7 days by trypan blue exclusion using the AutoT4 cell counter Cellometer (Nexcelom Bioscience, Lawrence, MA)